tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Seres Therapeutics Reports Q2 Results and Leadership Change
PremiumCompany AnnouncementsSeres Therapeutics Reports Q2 Results and Leadership Change
2M ago
Seres Therapeutics reports Q2 EPS ($2.27) vs ($4.34) last year
Premium
The Fly
Seres Therapeutics reports Q2 EPS ($2.27) vs ($4.34) last year
2M ago
Seres Therapeutics expects cash to fund operations into Q1 2026
Premium
The Fly
Seres Therapeutics expects cash to fund operations into Q1 2026
2M ago
Seres Therapeutics downgraded to Neutral from Buy at Chardan
PremiumThe FlySeres Therapeutics downgraded to Neutral from Buy at Chardan
5M ago
Seres Therapeutics Reports Positive Q1 2025 Results
Premium
Company Announcements
Seres Therapeutics Reports Positive Q1 2025 Results
5M ago
Seres Therapeutics’ Positive Earnings Call: Progress and Challenges
Premium
Company Announcements
Seres Therapeutics’ Positive Earnings Call: Progress and Challenges
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100